Nikhil Munshi, MD, Dana-Farber Cancer Institute, Boston, MA, shares his thoughts on how the addition of ciltacabtagene autoleucel (cilta-cel) and idecabtagene vicleucel (ide-cel) to the treatment paradigm is adding value to the treatment of patients with multiple myeloma. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
Categories
Most Popular Posts Today
Categories
A Leukemia Story Trailer 3 [Video]
I'm Currently Shooting This Documentary To Give Inspiration To Parents That There Is Hope At The End. This Documentary Is To ...
Join us for a live event on Mantle Cell Lymphoma (MCL) with Dr. Liat Dagan, a hematologist and oncology expert from Boca...
Most Popular This Week
« All Events November 5 @ 9:00 pm FREE « The String Cheese Incident Goose » Concert to Benefit Leukemia & Lymphoma Society. Live from Brooklyn Bowl Nashville. Stream on Twitch @TheRelixChannel. + Google Calendar+ iCal Export Details Date: November 5 Time: 9:00 pm Cost: FREE Website: https://www.twitch.tv/therelixchannel « The String Cheese Incident Goose »
Categories
Leukemia short Urdu video [Video]
shorts #leukemia #urdu #medical #video #leukemiaawareness #leukemiasurvivor Leukemia is a cancer of the blood, ...